ArticleMolecules (Basel, Switzerland)2025
Bond Valence Sum Parameters for Analyzing Pyranopterin Tungsten Enzyme Structures.
Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The determination of tungsten oxidation states and W-ligand bond lengths for pyranopterin tungsten enzymes can be negatively impacted by Fourier series termination effects and photodamage/photoreduction in the X-ray beam. As a result, a new set of bond valence sum (BVS) parameters have been derived from bond length data on W(+4) and W(+6) model compounds that were obtained from X-ray crystallography. These new W enzyme-specific BVS parameters have been used in the analysis of pyranopterin tungsten enzyme structural data. The results of this analysis indicate that there are potential issues with the enzyme crystal structures, including the number of ligating atoms to the tungsten atom, the W-ligand bond lengths, and the W oxidation state. We conclude that a BVS analysis of crystallographic and EXAFS structural data will help address these issues, and EXAFS should be more routinely employed in the determination of pyranopterin tungsten enzyme active site structures due to the increased accuracy of this technique for the determination of W-ligand bond distances.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.